Full-Time

Clinical Trial Assistant II

Clinical Operations Process and Systems

Updated on 1/1/2025

Revolution Medicines

Revolution Medicines

501-1,000 employees

Develops targeted therapies for RAS cancers

Biotechnology
Healthcare

Compensation Overview

$80k - $100kAnnually

Entry, Junior

San Carlos, CA, USA

Hybrid position requiring in-office presence.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Google Cloud Platform
Requirements
  • RN or bachelor’s degree in biological sciences or health-related field desired.
  • 0-1 years (CTA I)/1-3 years (CTA II) relevant experience in the pharmaceutical or biotech industry, preferably in Clinical Operations or Clinical Research-related experience.
  • Has knowledge of Good Clinical Practice (GCP) and International Conference on Harmonization (ICH) Guideline
  • Excellent written and verbal communication and interpersonal skills.
  • Demonstrate proficiency in Microsoft Office Suite (Outlook, MS Word, Excel, PowerPoint); MS Project and/or Smartsheet a plus.
  • Travel may be required (~10%).
Responsibilities
  • Adhere to Clinical Standard Operating Procedures (SOP) and Good Clinical Practice (GCP) and International Conference on Harmonization (ICH) Guidelines
  • Under guidance of manager, assist with the development, tracking and management of central Clinical Operations activities.
  • Assist with development of standard processes, tracking and documentation to facilitate efficient and high-quality Clinical Operations processes across clinical studies.
  • Assist with Clinical Operations Systems activities, such as maintenance of information in the Learning Management System (LMS), Clinical Trial Management System (CTMS), Medical Client Relationship Management (CRM) system or electronic Trial Master File (eTMF).
  • May support the selection and set up of new clinical systems (e.g., eTMF, CTMS).
  • Assist in the development, review, distribution, and archiving of study documents and reports (e.g., essential documents, plans, training materials, study guides, manuals, etc.).
  • May assist with set-up and maintenance of clinical study eTMF(s), if applicable, and work with the CRO or vendor to audit and resolve discrepancies.
  • Assist study teams with sample management, reconciliation and generate trial progress tracking system.
  • May liaise with Clinical Supply and other cross functional teams with processing shipments, returns, and assist with in-house drug, specimen, and ancillary supply reconciliation.
  • Provide support to address existing and potential gaps in the eTMF.
  • Support Clinical Operations during internal gap assessments and during inspections.
  • Support inspection readiness.
  • Track and prepare study-specific information utilizing databases, trackers, and other study tools.
  • Assist in the preparation of meeting materials, including scheduling, developing agendas, and minute-taking for internal Clinical Operations team meetings.
  • May conduct other activities to support study teams, such as gathering investigator and site information to support study start-up, maintenance, and close-out activities, contacting investigator sites to provide study specific information, working with cross-functional study teams and vendors to assist in the coordination of clinical trial activities.
  • May serve as the point of contact for vendors or study sites, study monitors for clinical supplies or document collection.
  • Support other clinical operations activities as appropriate.

Revolution Medicines focuses on developing treatments for cancers caused by RAS gene mutations, which are common in difficult-to-treat cancers like pancreatic, colorectal, and lung cancers. Their main product line includes RASON Inhibitors, designed to specifically target and inhibit RAS proteins that contribute to cancer growth. The company uses a Tri Complex Inhibitor platform to create these specialized therapies. Unlike many competitors, Revolution Medicines targets a niche market of RAS addicted cancers, working closely with healthcare providers and institutions to bring their therapies to patients. Their goal is to transform cancer treatment by providing effective, targeted therapies for patients suffering from these challenging cancers.

Company Stage

IPO

Total Funding

$219.8M

Headquarters

Redwood City, California

Founded

2014

Growth & Insights
Headcount

6 month growth

16%

1 year growth

40%

2 year growth

145%
Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of EQRx adds over $1 billion in capital for R&D.
  • FDA fast-tracking supports their RAS-targeted therapy pipeline.
  • Growing interest in targeted cancer therapies boosts investment opportunities.

What critics are saying

  • EQRx acquisition may pose integration challenges and cultural clashes.
  • $600M public stock offering could lead to shareholder dilution.
  • Focus on RAS-addicted cancers limits market scope and increases competition risk.

What makes Revolution Medicines unique

  • Revolution Medicines reconfigures natural substances into best-in-class cancer therapies.
  • Their Tri Complex Inhibitor platform targets RAS proteins driving cancer growth.
  • Exclusive license with University of Illinois enhances their unique synthesis technology.

Help us improve and share your feedback! Did you find this helpful?